Overview
- Searches are underway at seven locations in Chennai under the Prevention of Money Laundering Act, including homes of senior Tamil Nadu drug control officials and premises linked to Sresan Pharma.
- Tamil Nadu’s Drugs Control Department revoked Sresan’s manufacturing licence and shut the company, with the Kanchipuram unit sealed following contamination findings.
- Sresan owner G. Ranganathan was arrested on October 9 by the Madhya Pradesh SIT in the case, and he faces charges including culpable homicide and drug adulteration.
- Official lab reports on Batch SR-13, manufactured in May 2025, found about 46–48.6% diethylene glycol, and authorities have reported at least 20–22 child fatalities in Madhya Pradesh and Rajasthan.
- The CDSCO documented extensive compliance failures at Sresan and lapses by Tamil Nadu regulators, prompting suspensions of two senior drug inspectors and broader seizures and inspections.